News | March 16, 2026
Zuellig Pharma expands Cialis footprint across Asia
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The expanded ownership is expected to improve access to Cialis for millions of men in Asia affected by ED and BPH
The facility will manufacture the critical antibiotic intermediate Amino Cephalosporanic Acid (ACA), a key component in the production of cephalosporin antibiotics
Remidex manufactures micronutrient premixes and nutraceuticals,
One task, one interaction, one pair, experts advocate
The MAST trial is designed to test whether a single dose of pre-emptive, orally administered EBX-102-02 can protect and restore microbial diversity during transplantation
The Hydrus Microstent stands out as the first and only MIGS device backed by five-year clinical outcomes
The two companies will collaborate to evaluate Hopewell’s ttLNPs for clinical applications
This study evaluated a difficult-to-treat Crohn's disease patient population
The company has shown remarkable growth, posting a three-year CAGR of around 75% with an ARR of roughly Rs 100 crore and impressive gross margins
The facility is expected to become operational by FY2028-29
Subscribe To Our Newsletter & Stay Updated
